Anti-arrhythmic drug Archives - Medical Conferences

VANISH2: Antiarrhythmic drug therapy or catheter ablation in prior myocardial infarction complicated by ventricular tachycardia?

Presented By

Dr John Sapp, Queen Elizabeth II Health Sciences Centre, Canada

Trial

Phase 4, VANISH2

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 15:03

Early or delayed ablation for AF?

Presented By

Prof. Jonathan Kalman, Royal Melbourne Hospital, Australia

Conference

EHRA 2023

Type

News article

3 May 2023 16:18

Updates on anti-arrhythmic agents

Presented By

Prof. John Camm, St George’s University of London, UK

Conference

EHRA 2022

Type

Peer-reviewed article

1 June 2022 10:59

VANISH: Ablation reduces shock burden compared with anti-arrhythmic drug in ventricular tachycardia

Presented By

Prof. Michelle Samuel, University of Montreal, Canada

Trial

VANISH

Conference

EHRA 2022

Type

Peer-reviewed article

1 June 2022 10:26

Antiarrhythmic drug treatment in children: evidence-based recommendations

Presented By

Dr Nico Blom, Leiden University Medical Center, the Netherlands

Conference

EHRA 2021

Type

Peer-reviewed article

16 June 2021 17:09

Deep dive into EAST-AFNET 4 results on early rhythm-control in atrial fibrillation

Presented By

Dr Andreas Metzner, University Heart & Vascular Centre Hamburg, Germany

Trial

EAST-AFNET 4

Conference

EHA 2021

Type

Peer-reviewed article

16 June 2021 13:00

Cryo-FIRST study: improved AF and QoL outcomes with cryoballoon versus drug therapy

Presented By

Dr Nikola Pavlović, University Hospital Sestre Milosrdnice, Croatia

Trial

Phase 4, Cryo-FIRST

Conference

EHRA 2021

Type

Peer-reviewed article

16 June 2021 12:43